Loopbaan van Lynn Gallant
Eerdere bekende functies van Lynn Gallant
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ENVERIC BIOSCIENCES, INC. | Hoofd Techniek/Wetenschap/O&O | 22-02-2023 | 01-05-2023 |
BlueRock Therapeutics Canada ULC
 BlueRock Therapeutics Canada ULC BiotechnologyHealth Technology Bluerock Therapeutics engages in development of a pluripotent stem cell-derived myocardiocytes as regenerative cell therapies for restoring electrical and contractile function in patients with myocardial infarction or chronic heart failure. The company was founded by Gordon Keller and Lorenz Studer in 2016 and is headquartered in Toronto, Canada. | Hoofd Techniek/Wetenschap/O&O | - | - |
Opleiding van Lynn Gallant
| University of New England | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 3 |
| Canada | 2 |
Operationeel
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ENVERIC BIOSCIENCES, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
BlueRock Therapeutics Canada ULC
BlueRock Therapeutics Canada ULC BiotechnologyHealth Technology Bluerock Therapeutics engages in development of a pluripotent stem cell-derived myocardiocytes as regenerative cell therapies for restoring electrical and contractile function in patients with myocardial infarction or chronic heart failure. The company was founded by Gordon Keller and Lorenz Studer in 2016 and is headquartered in Toronto, Canada. | Health Technology |
- Beurs
- Insiders
- Lynn Gallant
- Ervaring
